Altareit SCA Kapitalrendite
Was ist das Kapitalrendite von Altareit SCA?
Kapitalrendite von Altareit SCA ist -40.48%
Was ist die Definition von Kapitalrendite?
Die Eigenkapitalrendite ist ein Maß für die Rentabilität eines Unternehmens im Verhältnis zum Buchwert des Eigenkapitals. Sie wird berechnet, indem das Nettoergebnis des Geschäftsjahres durch das gesamte Eigenkapital geteilt wird.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Kapitalrendite von Unternehmen in Real Estate Sektor auf EURONEXT im Vergleich zu Altareit SCA
Was macht Altareit SCA?
Altareit SCA operates as a real estate development company in France. The company develops residential properties, such as residential units and serviced residences; and mixed-use projects and business properties. Altareit SCA was founded in 1955 and is headquartered in Paris, France. Altareit SCA operates as a subsidiary of Altarea SCA.
Unternehmen mit kapitalrendite ähnlich Altareit SCA
- Genfit SA hat Kapitalrendite von -40.57%
- Cobra Resources plc hat Kapitalrendite von -40.53%
- Athene hat Kapitalrendite von -40.51%
- Athene hat Kapitalrendite von -40.51%
- Fairfax Africa hat Kapitalrendite von -40.51%
- Aytu BioPharma Inc hat Kapitalrendite von -40.50%
- Altareit SCA hat Kapitalrendite von -40.48%
- ArtGo hat Kapitalrendite von -40.47%
- Kura Oncology Inc hat Kapitalrendite von -40.43%
- Great Ajax Corp hat Kapitalrendite von -40.43%
- Epigenomics AG hat Kapitalrendite von -40.41%
- Business & Decision SA hat Kapitalrendite von -40.39%
- Clover Health Investments Corp hat Kapitalrendite von -40.37%